Guidelines for Trypanosoma cruzi-HIV Co-infection and other Immunosuppressive Conditions: Diagnosis, Treatment, Monitoring, and Implementation from the International Network of Care and Studies - 2023
- PMID: 38088667
- PMCID: PMC10706049
- DOI: 10.1590/0037-8682-0549-2023
Guidelines for Trypanosoma cruzi-HIV Co-infection and other Immunosuppressive Conditions: Diagnosis, Treatment, Monitoring, and Implementation from the International Network of Care and Studies - 2023
Conflict of interest statement
References
-
- Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa AS, Sartori AMC, Santana RC, et al. Correction: Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions". PLoS Negl Trop Dis. 2023;17(1):e0011036. doi: 10.1371/journal.pntd.0011036. Erratum for: PLoS Negl Trop Dis . 2021 Sep 30;15(9):e0009809. - DOI - PMC - PubMed
-
- Ministério da Saúde (MS). Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) Protocolo Clínico e Diretrizes Terapêuticas Doença de Chagas. Brasília: MS; 2018. 135 p. http://antigo-conitec.saude.gov.br/images/PCDT_Doenca_de_Chagas.pdf
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
